PharmaceuticalsOceanside, CaliforniaAnnouncement date · Feb 10, 2023

Oceanside Next-Generation Commercial Biologics Facility

See all projects by Roche Group →

Genentech, a wholly owned Roche Group member, added a next-generation commercial biologics facility at its Oceanside campus at One Antibody Way in San Diego County, California. The company broke ground February 10, 2023 on the modular, digitally enabled plant for flexible commercial production of biologics for smaller patient populations, including rare diseases and personalised medicines. Genentech committed approximately $450 million in advanced manufacturing capability and approximately 150 new local full-time operating jobs. The company targeted early 2025 operations, and its current campus profile describes the facility as part of the active commercial manufacturing network; no exact production-start day has been published, so AFT records no opening date. This is the site-specific $450 million component of a broader California manufacturing program; the separate broader-program references, construction-trade employment and pre-existing campus jobs are excluded.

Investment
$450.0M
Permanent jobs announced
150
Status
Operational
Operations began
Date not publicly specified
Why this project qualifies

With $450 million in facility-specific investment and 150 permanent operating jobs announced, this project clears both of AFT's qualifying thresholds ($100 million in facility-specific investment OR 100 permanent operating jobs). This project also meets AFT's primary-source verification and physical U.S. manufacturing-footprint requirements.

View full methodology →
Why it matters

The pharmaceuticals context.

Pharmaceutical manufacturers are committing billions to new U.S. production capacity for active ingredients, injectable medicines, biologics and other high-demand treatments. North Carolina and Indiana remain major centers of investment, while new facilities are being planned across the South. The current project pipeline includes both large greenfield campuses and major expansions of established production sites.

Project record

At a glance

Company
Roche Group (Genentech)
Industry
Pharmaceuticals
Location
Oceanside, California
Investment
$450.0M
Permanent jobs announced
150
Status
Operational
Announced
Feb 10, 2023
Operations began
Date not publicly specified
Added to tracker
Sep 1, 2026
Sources

Official references

Related

Other projects to know

In California
Across Pharmaceuticals
Back to the tracker/projects/roche-genentech-oceanside-commercial-biologics-facility